Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy

Cancer stem cell (SC) chemoresistance may be responsible for the poor clinical outcome of non-small-cell lung cancer (NSCLC) patients. In order to identify the molecular events that contribute to NSCLC chemoresistance, we investigated the DNA damage response in SCs derived from NSCLC patients. We fo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bartucci, M, Svensson, S, Romania, P, Dattilo, R, Patrizii, M, Signore, M, Navarra, S, Lotti, F, Biffoni, M, Pilozzi, E, Duranti, E, Martinelli, S, Rinaldo, C, Zeuner, A, Maugeri-Saccà, M, Eramo, A, De Maria, R
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2012
Assuntos:
Original Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3321626/
https://ncbi.nlm.nih.gov/pubmed/22117197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cdd.2011.170
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares